Chrysiis Michaloglou

Author

Also Known As

C Michaloglou, Chrysiis Michaloglou

Publications

Citations

H-Index

Concepts

All Affiliations

Chrysiis Michaloglou is an author at The Netherlands Cancer Institute specializing in cell biology, medicine, and cell death.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	4.2K
2	Cell Biology	3	3	4.2K
3	Natural Sciences	1	1	93
4	Biochemistry	1	1	93
5	Immunology	1	1	2K

Chrysiis Michaloglou

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
BRAFE600-associated senescence-like cell cycle arrest of human naevi Chrysiis Michaloglou, Liesbeth C.W. Vredeveld, Marı́a S. Soengas, Nature AgingCell DivisionMedicineCellular SenescenceHuman Naevi	2005	2.1K
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network Thomas Kuilman, Chrysiis Michaloglou, Liesbeth C.W. Vredeveld, Cell InflammationCytokineAutoimmune DiseaseImmunologyChronic Inflammation	2008	2K
Abrogation of BRAF<sup>V600E</sup>-induced senescence by PI3K pathway activation contributes to melanomagenesis Liesbeth C.W. Vredeveld, Patrícia A. Possik, Marjon A. Smit, Genes & Development	2012	256
Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer Chrysiis Michaloglou, Claire Crafter, Oona Delpuech, Molecular Cancer Therapeutics	2018	188
The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity Chrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin, PLoS ONE Negative RegulatorMolecular RegulationPtpn14 Ppxy MotifCell DeathTumor Biology	2013	93
PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors Anna D. Staniszewska, Joshua Armenia, Matthew King, OncoImmunology	2022	46

Page 1